Blood test accurate, consistent at spotting Alzheimer’s, dementia-linked proteins
By
Kristen Fischer
Jan 24, 2024
A new blood test that can spot amyloid and tau in the brain should be on the market soon. The test worked well to accurately and consistently identify accumulations of the proteins implicated in Alzheimer’s...
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
By
Alicia Lasek
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
As negative thoughts accumulate, so might Alzheimer’s risk
By
Alicia Lasek
Jun 08, 2020
Repetitive negative thinking is linked to cognitive decline and brain deposits seen in early Alzheimer’s disease, a new study has found.
High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.
Moderate drinkers have lower amyloid-beta levels, study finds
By
Alicia Lasek
Mar 25, 2020
Older adults who drank one to 13 standard drinks a week over many years had a 66% lower rate of beta amyloid deposits, as shown in brain scans.
Blood test detects early Alzheimer’s with 94% accuracy
By
Alicia Lasek
Aug 01, 2019
A blood test that helps to detect early Alzheimer’s disease is one step closer to clinical use. Its accuracy and low cost are game changers, researchers say.
CMS: Medicare will not cover PET scans for Alzheimer’s
By
Tim Mullaney
Oct 04, 2013
Seniors will not be able to receive Medicare coverage for imaging scans to help diagnose Alzheimer’s disease, the Centers for Medicare & Medicaid Services recently announced.
Common medications trigger Alzheimer’s, researchers find
By
McKnight's Staff
Jun 13, 2013
Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research.